Research Suggests Blocking Caspase-1 Enzyme May Suppress Lung Cancer

A study published in *Science Advances* by a Massachusetts Institute of Technology (MIT) research team indicates that inhibiting the enzyme 'caspase-1,' which is involved in lung inflammation, can reduce the incidence of lung cancer in mice. This research offers a promising avenue for future treatment development, especially since a caspase-1 inhibitor, belnacasan, has already undergone human clinical trials for other conditions.